SCHEMBL6851948

SCHEMBL6851948

S=[C]NCc1cccc2oc3ccccc3c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 3/20 0.39
EGFR P00533 2/20 0.39
FLT4 P35916 2/20 0.39
KDR P35968 2/20 0.39
CYP17A1 P05093 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
MAOA P21397 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 2/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36
PGAM1 P18669 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6007598 0.84 MAOA (0.40) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL6851954 0.77 IGF1R (0.39) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL6007604 0.74 ADH1B (0.42) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL2954355 0.73 MAOA (0.47) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL26044892 0.73 CHRM2 (0.46) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL9425618 0.72 MAOA (0.48) CYP17A1CYP19A1CYP11B1CYP11B2MAOA
SCHEMBL19802189 0.72 ALOX5 (0.44) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL754169 0.72 ALDH1A1 (0.43) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL7035976 0.72 ALDH1A1 (0.43) IGF1REGFRFLT4KDRCYP17A1
SCHEMBL13201404 0.72 ALDH1A1 (0.43) IGF1REGFRFLT4KDRCYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
US-20040053923-A1 Novel isoindole derivatives BANYU PHARMACEUTICAL CO., LTD. 2004-03-18 US disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053923-A1 Novel isoindole derivatives GPR119, SLC5A2, SLC5A1 IGF1R 183/4885EGFR 3388/4885FLT4 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.